Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: Final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study / Baccarani, Michele; Druker, Brian J.; Branford, Susan; Kim, Dong Wook; Pane, Fabrizio; Mongay, Lidia; Mone, Manisha; Ortmann, Christine Elke; Kantarjian, Hagop M.; Radich, Jerald P.; Hughes, Timothy P.; Cortes, Jorge E.; Guilhot, François. - In: INTERNATIONAL JOURNAL OF HEMATOLOGY. - ISSN 0925-5710. - 99:5(2014), pp. 616-624. [10.1007/s12185-014-1566-2]
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: Final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study
PANE, FABRIZIO;
2014
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
